|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Prosigna® Breast Cancer Prognostic Gene Signature Assay
Test Code92125
CPT Codes
81520
Preferred Specimen
Formalin-fixed, paraffin-embedded tissue block submitted in an IHC transport kit
Other Acceptable Specimens
6 unstained (minimum: 3 slides), 10-micron slides submitted in a tissue transport kit
Instructions
Surgical pathology report required.
Formalin fix (10 percent neutral buffered formalin) and paraffin embed excised tissue. Protect from excessive heat. Transport tissue block or 6 unstained 10-micron slides. (minimum: 3 slides). Transport block(s) and/or slide(s) in a tissue transport kit (recommended but not required).
Formalin fix (10 percent neutral buffered formalin) and paraffin embed excised tissue. Protect from excessive heat. Transport tissue block or 6 unstained 10-micron slides. (minimum: 3 slides). Transport block(s) and/or slide(s) in a tissue transport kit (recommended but not required).
Transport Temperature
Room temperature
Specimen Stability
Room temperature: Indefinitely
Refrigerated: Indefinitely
Frozen: Unacceptable
Refrigerated: Indefinitely
Frozen: Unacceptable
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Specimens fixed/processed in alternative fixatives (alcohol, Prefer) • Decalcified specimens • Needle core biopsy • Less than 10 percent tumor
Methodology
Hybridization/gene expression
Setup Schedule
Set up: Varies; Report available: 13-15 days
Reference Range
See Laboratory Report
Clinical Significance
Assess the risk of distant recurrence in post-menopausal women with early stage (stage I or stage II), hormone receptor-positive (ER+ and/or PR+) breast cancer. Useful in both node-negative and node-positive (1-3 nodes) disease.